E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk

Journal of Cell Biology

Volumn 140, Issue 3, 1998, Pages 637-645

  Lavoie, Josée N ^a   Nguyen, M ^a   Marcellus, R C ^a   Branton, P E ^a   Shore, G C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; DNA; DOXYCYCLINE; PHOSPHATIDYLSERINE; PROTEIN BCL 2; PROTEIN P53; TETRAPEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRUS E4 PROTEINS; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CHO CELLS; CRICETINAE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; DOXYCYCLINE; GENE EXPRESSION; GENES, BCL-2; GENES, REPORTER; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; PHOSPHATIDYLSERINES; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; RODENTIA;

EID: 0032498630     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.140.3.637     Document Type: Article

References (77)

1. Bates, S., and K.H. Vousden. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:12-19.
2. Boise, L.H., and C.B. Thompson. 1997. BclxL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:3759-3764.
3. Boulakia, C.A., G. Chen, F.W. Ng, J.G. Teodoro, P.E. Branton, D.W. Nicholson, G.G. Poirier, and G.C. Shore. 1996. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene. 12:529-535.
4. Casciola, R.L., D.W. Nicholson, T. Chong, K.R. Rowan, N.A. Thornberry, D.K. Miller, and A. Rosen. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957-1964.
5. Castedo, M., T. Hirsh, S.A. Susin, N. Zamzami, P. Marchetti, A. Macho, and G. Kroemer. 1996. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 157:512-521.
6. Chang, B.S., A.J. Minn, S.W. Muchmore, S.W. Fesik, and C.B. Thompson. 1997. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO (Eur. Mol. Biol. Organ.) J. 16:968-977.
7. Chen, G., P.E. Branton, and G.C. Shore. 1995. Induction of p53-independent apoptosis by hygromycin B: suppression by Bcl-2 and adenovirus E1B 19-kDa protein. Exp. Cell Res. 221:55-59.
8. Chen, G., P.E. Branton, E. Yang, S.J. Korsmeyer, and G.C. Shore. 1996. Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271:24221-24225.
9. Chen, L.B. 1989. Fluorescent labeling of mitochondria. Methods Cell Biol. 29:103-123.
10. Chinnaiyan, A.M., and V.M. Dixit. 1996. The cell-death machine. Curr. Biol. 6:555-562.
11. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:849-852.
12. Cohen, J.J. 1991. Programmed cell death in the immune system. Adv. Immunol. 50:55-85.
13. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
14. Duriez, P.J., S. Desnoyers, J.C. Hoflack, G.M. Shah, B. Morelle, S. Bourassa, G. Poirier, and B. Talbot. 1997. Characterization of anti-peptide antibodies directed towards the automodification domain and apoptotic fragment of poly (ADP-ribose) polymerase. Biochim. Biophys Acta. L1334:65-72.
15. Dyson, N., and E. Harlow. 1992. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12:161-195.
16. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
17. Farrow, S.N., and R. Brown. 1996. New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev. 6:45-49.
18. Fernandes-Alnemri, T., G. Litwack, and E.S. Alnemri. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 269:30761-30764.
19. Fraser, A., and G. Evan. 1996. A license to kill. Cell. 85:781-784.
20. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:5547-5551.
21. Gossen, M., S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1766-1769.
22. Haldar, S., N. Jena, and C.M. Croce. 1995. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA. 92:4507-4511.
23. Han, Z., D. Chatterjee, D.M., J. Early, P. Pantazis, J.H. Wyche, and E.A. Hendrickson. 1995. Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation. Mol. Cell. Biol. 15:5849-5857.
24. Kimelman, D.J., J.S. Miller, D. Porter, and B.E. Roberts. 1985. E1A regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related. J. Virol. 53:399-409.
25. Kleinberger, T., and T. Shenk. 1993. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J. Virol. 67:7556-7560.
26. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:614-620.
27. Kroemer, G., P.X. Petit, N. Zamzami, J.-L. Vayssière, and R. Mignotte. 1995. The biochemistry of apoptosis. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:1277-1287.
28. Lavoie, J.N., H. Lambert, E. Hickey, L.A. Weber, and J. Landry. 1995. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell. Biol. 15:505-516.
29. Lavoie, J.N., G. L'Allemain, A. Brunet, R. Müller, and J. Pouysségur. 1996a. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616.
30. Lavoie, J.N., N. Rivard, G. L'Allemain, and J. Pouysségur. 1996b. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog. Cell Cycle Res. 2:49-58.
31. Levine, A.J. 1993. The tumor suppressor genes. Annu. Rev. Biochem. 62:623-651.
32. Liebermann, D.A., B. Hoffman, and R.A. Steinman. 1995. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene. 11:199-210.
33. Lin, Y., and S. Benchimol. 1995. Cytokines inhibit p53-dependent apoptosis but not p53-mediated G1 arrest. Mol. Cell. Biol. 15:6045-6054.
34. Lowe, S.W., and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
35. Lowe, S.W., T. Jacks, D.E. Housman, and H.E. Ruley. 1994. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA. 91:2026-2030.
36. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993a. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:957-967.
37. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:847-849.
38. Marcellus, R.C., J.C. Teodoro, T. Wu, D.E. Brough, G. Ketner, G.C. Shore, and P.E. Branton. 1996. Adenovirus 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. J. Virol. 70:6207-6215.
39. Martin, S.J., C.P.M. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C.A.A. van Schie, D.M. LaFace, and D.R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initialing stimulus: inhibition by overexpression of Bcl-2 and Ab1. J. Exp. Med. 182:1545-1556.
40. Miyashita, T., and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:293-299.
41. Miyashita, T., S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman, and J.C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799-1805.
42. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3:63-70.
43. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
44. Ng, F.W.H., M. Nguyen, T. Kwan, P.E. Branton, D.W. Nicholson, J.A. Cromlish, and G.C. Shore. 1997. p28 BAP31, a Bcl-2/Bcl-XL- and Pro-caspase 8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139:327-338.
45. Nguyen, M., P.E. Branton, P.A. Walton, Z.N. Oltvai, S.J. Korsmeyer, and G.C. Shore. 1994. Role of membrane anchore domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem. 269:16521-16524.
46. Nicholson, D.W., A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:37-43.
47. Öhman, K., K. Nordqvist, and G. Akusjärvi. 1993. Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation. Virology. 194:50-58.
48. Oltvai, Z.N., and S.J. Korsmeyer. 1994. Checkpoints of dueling dimers foil death wishes. Cell. 79:189-192.
49. Petit, P.X., H. LeCoeur, E. Zorn, C. Dauguet, B. Mighotte, and M.L. Gourgeon. 1995. Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell. Biol. 130:157-167.
50. Polverino, A.J., and S.D. Patterson. 1997. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor. J. Biol. Chem. 272:7013-7021.
51. Querido, E., J.G. Teodora, and P.E. Branton. 1997. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J. Virol. 71:3526-3533.
52. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:7742-7746.
53. Reed, J.C. 1997. Double identity for proteins of the Bcl-2 family. Nature. 387:773-776.
54. Sabbatini, P., J. Han, S.K. Chiou, D.W. Nicholson, and E. White. 1997. Interleukin 1 β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ. 8:643-653.
55. Sakamuro, D., V. Eviner, K.J. Elliott, L. Showe, E. White, and G.C. Prendergast. 1995. c-myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 11:2411-2418.
56. Schlegel, J., I. Peters, S. Orronius, D.K. Miller, N.A. Thornberry, T.T. Yamin, and D.W. Nicholson. 1996. CPP32/apopain is a key interleukin 1 β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271:1841-1844.
57. Selvakumaran, M., H.K. Lin, T. Miyashita, H.G. Wang, S. Krajewski, J.C. Reed, B. Hoffman, and D. Liebermann. 1994. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene. 9:1791-1798.
58. Slee, E.A., H. Zhu, S.C. Chow, M. MacFarlane, D.W. Nicholson, and G.M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21-24.
59. Stanbridge, E.J., and P.C. Nowell. 1990. Origins of human cancer revisited. Cell. 63:867-874.
60. Strack, P.R., M.W. Frey, C.J. Rizzo, B. Cordova, H.J. George, R. Meade, S.P. Ho, J. Corman, R. Tritch, and B.D. Korant. 1996. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA. 93:9571-9576.
61. Strasser, A., A.W. Harris, T. Jacks, and S. Cory. 1994. DNA damage can induce apoptosis in proliferating lymphiod cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:329-339.
62. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science. 267:1445-1449.
63. Teodoro, J.G., and P.E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739-1746.
64. Teodoro, J.G., G.C. Shore, and P.E. Branton. 1995. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene. 11:467-474.
65. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen, and V.M. Dixit. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:801-809.
66. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
67. Wagner, A.J., J.M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/Cip1. Genes Dev. 8:2817-2830.
68. White, E., and L.R. Gooding. 1994. Regulation of apoptosis by human adenoviruses. In Apoptosis: The Molecular Basis for Cell Death II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 111-141.
69. White, E., R. Cipriani, P. Sabbatini, and A. Danton. 1991. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:2968-2978.
70. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:555-556.
71. Xiang, J., D.T. Chao, and S.J. Korsmeyer. 1996. Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:14559-14563.
72. Yang, E., and S.J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:386-401.
73. Zamzami, N., P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S.A. Susin, P.X. Petit, B. Mignotte, and G. Kroemer. 1995a. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:367-377.
74. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.-L. Vayssière, P.X. Petit, and G. Kroemer. 1995b. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661-1672.
75. Zamzami, N., S.A. Susin, P. Marchetti, T. Hirsch, M. Castedo, and G. Kroemer. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544.
76. Zha, J., H. Harada, E. Yang, J. Jockei, and S.J. Korsmeyer. 1996. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not BclxL. Cell. 87:619-628.
77. Zhu, H., H.O. Fearnhead, and G.M. Cohen. 1995. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS (Fed. Eur. Biochem. Soc.) Lett. 374:303-308.